Prevention and Treatment of Tobacco Use JACC Health Promotion Series (Reprinted from J Am Coll Cardiolvol, vol 72, pg 1030-45, 2018)

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

卷:72

Reprint

Kalkhoran, Sara^1,2  Benowitz, Neal L.^3,4  Rigotti, Nancy A.^1,2 

[1] Massachusetts Gen Hosp, Dept Med, Div Gen Internal Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA

[2] Harvard Med Sch, Dept Med, Boston, MA USA

[3] Univ Calif San Francisco, Dept Med, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA USA

[4] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA USA

关键词: nicotine;    smoking;    smoking cessation;    smoking prevention;    tobacco use disorder;   

DOI  :  10.1016/j.jacc.2018.10.020

来源: Elsevier

【 摘 要 】

Tobacco use is the leading preventable cause of death worldwide and is a major risk factor for cardiovascular disease' (CVD). Both prevention of smoking initiation among youth and smoking cessation among established smokers are key for reducing smoking prevalence and the associated negative health consequences. Proven tobacco cessation treatment includes pharmacotherapy and behavioral support, which are most effective when provided together. First'line medications (varenicline, bupropion, and nicotine replacement) are effective and safe for patients with CVD. Clinicians who care for patients with CVD should give as high a priority to treating tobacco use as to managing other CVD risk factors. Broader tobacco control efforts to raise tobacco taxes, adopt smoke-free laws, conduct mass media campaigns, and restrict tobacco marketing enhance clinicians' actions working with individual smokers. (C) 2018 by the American College of Cardiology Foundation.

【 授权许可】

Free